Physical Functional Side Effects of Taxane Chemotherapy for Breast Cancer
Determine the characteristics of symptoms and functional impairment associated with chemotherapy induced peripheral neuropathy.
|Official Title:||Physical Functional Side Effects of Taxane Chemotherapy for Breast Cancer|
|Study Start Date:||June 2010|
|Study Completion Date:||April 2011|
|Primary Completion Date:||April 2011 (Final data collection date for primary outcome measure)|
Taxanes, a type of chemotherapeutic agent prescribed to breast cancer patients, have a known physical side effect of chemotherapy induced peripheral neuropathy (CIPN). The purpose of this qualitative study is to understand the experience and physical functional side effects of taxanes. This is the first of a two phase study. The overall goal is to identify existing objective physical performance measures to assess functional side effects of taxanes.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01153282
|United States, Pennsylvania|
|Abramson Cancer Center of the University of Pennsylvania|
|Philadelphia, Pennsylvania, United States, 19104|
|Principal Investigator:||Rebecca Speck, MPH||Abramson Cancer Center of the University of Pennsylvania|